ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,105, issued on March 31, was assigned to ELI LILLY AND COMPANY (Indianapolis).
"KRas G12C inhibitors" was invented by David Michael Hyman (Westport, Conn.), Gregory Lawrence Lackner (Indianapolis), Sheng-Bin Peng (Carmel, Ind.), Bree Leigh Richey (Indianapolis) and Chong Si (Zionsville, Ind.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of the formula:where R1, R2, R3, R4, R5, A, and B are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and salts for treating patients for cancer."
The patent was filed on Nov. 24, 2021, under Application No. 18/255,713....